Theriva Biologics Inc (TOVX)

1.75 +0.25 (+16.67%) USD  |  NYAM  |  Dec 31, 16:00
1.72 -0.03 (-1.71%) After-Hours: 20:00
More

Theriva Biologics Research and Development Expense (Annual): 14.31M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Merck & Co Inc 30.53B
Pro-Dex Inc 3.189M
NovaBay Pharmaceuticals Inc 0.068M
Palatin Technologies Inc 22.40M
iBio Inc 5.185M